Private Capital Group’s Elevance Health ELV Stock Holding History

Private Capital Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$130K	Sell	269 -85	-24%	-$42K	0.1%	206
2022 Q1	$174K	Buy	354 +5	+1%	+$2.29K	0.04%	250
2021 Q4	$162K	Sell	349 -29	-8%	-$12.2K	0.03%	286
2021 Q3	$141K	Buy	378 +95	+34%	+$36.1K	0.03%	306
2021 Q2	$108K	Buy	283 +15	+6%	+$5.73K	0.02%	388
2021 Q1	$96K	Sell	268 -6	-2%	-$1.93K	0.02%	401
2020 Q4	$88K	Sell	274 -166	-38%	-$50.9K	0.02%	554
2020 Q3	$118K	Buy	440 +164	+59%	+$44.1K	0.02%	404
2020 Q2	$73K	Buy	276 +37	+15%	+$9.87K	0.02%	558
2020 Q1	$54K	Buy	239 +43	+22%	+$11.7K	0.01%	608
2019 Q4	$59K	Sell	196 -123	-39%	-$33.8K	0.01%	650
2019 Q3	$77K	Buy	319 +109	+52%	+$29.9K	0.01%	573
2019 Q2	$50K	Sell	210 -110	-34%	-$30K	0.01%	665
2019 Q1	$92K	Sell	320 -77	-19%	-$22.3K	0.02%	498
2018 Q4	$104K	Hold	397	–	–	0.02%	378
2018 Q3	$108K	Sell	397 -4	-1%	-$1.04K	0.02%	401
2018 Q2	$95K	Hold	401	–	–	0.02%	441
2018 Q1	$88K	Sell	401 -3	-0.7%	-$705	0.02%	450
2017 Q4	$91K	Buy	+404	New	+$86K	0.02%	450

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Private Capital Group's ELV Position: Q2 2022 in Review

Private Capital Group reduced its Elevance Health (ELV) stake by 24% in Q2 2022, selling an estimated $42K and leaving 269 shares worth $130K. The position accounts for 0.1% of the portfolio, ranked #206.

Private Capital Group first reported a position in ELV in Q4 2017 and has held it in 19 quarters since. The position peaked at $174K in Q1 2022. 1,441 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Private Capital Group held 269 shares of Elevance Health worth $130K as of Q2 2022.
Private Capital Group sold 85 Elevance Health shares in Q2 2022, an estimated $42K.
Elevance Health made up 0.1% of Private Capital Group's portfolio in Q2 2022, its #206 holding.
Private Capital Group first reported a position in Elevance Health in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's Elevance Health position peaked at $174K in Q1 2022.
1,441 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.